JP2017525671A5 - - Google Patents

Download PDF

Info

Publication number
JP2017525671A5
JP2017525671A5 JP2017500060A JP2017500060A JP2017525671A5 JP 2017525671 A5 JP2017525671 A5 JP 2017525671A5 JP 2017500060 A JP2017500060 A JP 2017500060A JP 2017500060 A JP2017500060 A JP 2017500060A JP 2017525671 A5 JP2017525671 A5 JP 2017525671A5
Authority
JP
Japan
Prior art keywords
particles
micronized
diameter
walton
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017500060A
Other languages
English (en)
Japanese (ja)
Other versions
JP6640826B2 (ja
JP2017525671A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/039444 external-priority patent/WO2016007554A1/en
Publication of JP2017525671A publication Critical patent/JP2017525671A/ja
Publication of JP2017525671A5 publication Critical patent/JP2017525671A5/ja
Application granted granted Critical
Publication of JP6640826B2 publication Critical patent/JP6640826B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017500060A 2014-07-08 2015-07-07 微粒子化ワルトン膠質 Active JP6640826B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462022084P 2014-07-08 2014-07-08
US62/022,084 2014-07-08
PCT/US2015/039444 WO2016007554A1 (en) 2014-07-08 2015-07-07 Micronized wharton's jelly

Publications (3)

Publication Number Publication Date
JP2017525671A JP2017525671A (ja) 2017-09-07
JP2017525671A5 true JP2017525671A5 (enExample) 2018-08-16
JP6640826B2 JP6640826B2 (ja) 2020-02-05

Family

ID=55064792

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500060A Active JP6640826B2 (ja) 2014-07-08 2015-07-07 微粒子化ワルトン膠質

Country Status (5)

Country Link
US (3) US20160008410A1 (enExample)
EP (1) EP3167049A4 (enExample)
JP (1) JP6640826B2 (enExample)
AU (1) AU2015287920A1 (enExample)
WO (1) WO2016007554A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1933852B1 (en) 2005-09-27 2018-12-19 TissueTech, Inc. Amniotic membrane preparations and purified compositions and methods of use
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
ES2822301T3 (es) 2011-06-10 2021-04-30 Tissuetech Inc Métodos de procesamiento de tejidos de soporte fetal
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
US10342830B2 (en) 2015-01-05 2019-07-09 Gary M. Petrucci Methods and materials for treating lung disorders
TW201642914A (zh) 2015-02-23 2016-12-16 組織科技股份有限公司 用於治療眼部疾病及失調的裝置及方法
WO2016187555A1 (en) 2015-05-20 2016-11-24 Tissuetech, Inc. Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
WO2017136557A1 (en) 2016-02-05 2017-08-10 Petrucci Gary M Methods and materials for treating nerve injuries and neurological disorders
KR102354954B1 (ko) 2016-04-04 2022-01-24 오메자 엘엘씨 어유 국소 조성물
US10478531B2 (en) * 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
EP3955940A4 (en) * 2019-04-16 2023-01-04 Lifenet Health Birth tissue-derived products and preparation and uses thereof
US20220280573A1 (en) * 2021-03-03 2022-09-08 Axogen Corporation Human umbilical cord-derived compositions and uses thereof for treating neuropathy
WO2022186946A1 (en) * 2021-03-03 2022-09-09 Axogen Corporation Human umbilical cord-derived compositions and uses thereof for treating neuropathy
WO2023164799A1 (zh) * 2022-03-01 2023-09-07 傅毓秀 可促进骨质新生的瓦顿氏凝胶制品

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453638A1 (fr) 1979-04-10 1980-11-07 Bontemps Raymond Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
CA2060223C (en) * 1991-02-12 1999-07-20 Clarence C. Lee Injectable medical lubricating fluid composition and method of use
US5558071A (en) 1994-03-07 1996-09-24 Combustion Electromagnetics, Inc. Ignition system power converter and controller
US5919702A (en) * 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
IL134830A0 (en) 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
CN1487836A (zh) 2000-03-14 2004-04-07 埃米林药品公司 胰高糖素样肽1(7-36)对胃窦幽门十二指肠能动性的影响
AU2002362932B2 (en) * 2001-10-18 2008-06-19 Lifecell Corporation Remodeling of tissues and organs
ES2363978T3 (es) 2004-02-13 2011-08-22 Cognis France, S.A.S. Uso de composiciones cosméticas que comprenden un extracto de las hojas de castanea sativa.
US9005646B2 (en) 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
WO2008021391A1 (en) 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
KR101329658B1 (ko) 2006-09-25 2013-11-14 아처 다니엘 미드랜드 캄파니 초흡수성 표면처리된 카르복시알킬화 다당류 및 그 제조방법
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
EP2197270B8 (en) 2007-09-07 2020-03-04 Surgical Biologics, LLC Placental tissue grafts and improved methods of preparing and using the same
CN104224703A (zh) 2008-09-25 2014-12-24 赛福伦公司 苯达莫司汀的液体配制品
AU2008362567B2 (en) * 2008-10-10 2015-11-12 Histocell S.L. New biomaterial based on wharton's jelly from the human umbilical cord
EP2470231B1 (en) 2009-08-25 2019-10-09 Tissue Tech, Inc. Umbilical cord amniotic membrane products
CN102198292B (zh) 2010-03-26 2013-06-26 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
WO2012112410A2 (en) 2011-02-14 2012-08-23 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
CA2826377C (en) * 2011-02-14 2020-12-15 Mimedx Group Inc. Laminated tissue grafts composed of wharton's jelly and methods of making and using the same
JP6081378B2 (ja) 2011-02-14 2017-02-15 ミメドックス グループ インコーポレーティッドMimedx Group Inc. 微粉化胎盤組織の組成物ならびにそれを作成および使用する方法
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
WO2013016444A2 (en) * 2011-07-27 2013-01-31 Polyone Corporation Crosslinkable bioplasticizers
US12290613B2 (en) * 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
EP2798058B1 (en) 2011-12-30 2017-10-18 Amit Patel Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses
US9943551B2 (en) 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
CA2880157C (en) 2012-08-15 2020-07-21 Mimedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US8904664B2 (en) 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
US10449220B2 (en) * 2013-08-30 2019-10-22 Mimedx Group, Inc. Micronized placental compositions comprising a chelator
US20150335686A1 (en) * 2014-05-21 2015-11-26 Mimedx Group, Inc. Micronized wharton's jelly
US20160000968A1 (en) 2014-07-07 2016-01-07 Mimedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same

Similar Documents

Publication Publication Date Title
JP2017525671A5 (enExample)
Sharma et al. An insight into functionalized calcium based inorganic nanomaterials in biomedicine: Trends and transitions
Najafi-Hajivar et al. Overview on experimental models of interactions between nanoparticles and the immune system
JP2017517255A5 (enExample)
AU2015287920A8 (en) Micronized Wharton's Jelly
MX2021007794A (es) Composiciones y metodos para aplicaciones oftalmicas y/u otras aplicaciones.
JP2014240439A5 (enExample)
JP2016504362A5 (enExample)
MY188825A (en) High-concentration monoclonal antibody formulations
MX2009012279A (es) Distribucion de micro y nanoparticulas con plaquetas.
WO2017100700A3 (en) Peptides for renal therapy
JP2014000094A5 (ja) 臍帯由来細胞を用いた局部的または散在的脳外傷の改善
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
WO2014194254A8 (en) Treatment of cancers using pi3 kinase isoform modulators
PH12017500479B1 (en) Liquid inhalation formulation comprising rpl554
JP2014526447A5 (enExample)
BR112013027674A2 (pt) "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha".
MX2014000141A (es) Agentes de enlace a receptor de canabinoide, composiciones y metodos.
IL294463A (en) Methods for treating or preventing eye conditions
JP2014509319A5 (enExample)
JP2014218522A5 (enExample)
WO2015152693A3 (ko) 신규 이중 나선 올리고 rna 및 이를 포함하는 섬유증 또는 호흡기 질환의 예방 또는 치료용 약학조성물
Gomzikova et al. Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells
CO2017007137A2 (es) Composición farmacéutica que comprende plasminógeno y usos de este
MX2015015589A (es) Composiciones y metodos para el suministro de agentes activos hidrófobos.